BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33553242)

  • 1. CLEC3B as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
    Xie XW; Jiang SS; Li X
    Front Mol Biosci; 2020; 7():614034. PubMed ID: 33553242
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Xie X; Jiang S; Li X
    Front Oncol; 2021; 11():621373. PubMed ID: 33767990
    [No Abstract]   [Full Text] [Related]  

  • 3. CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment.
    Sun J; Xie T; Jamal M; Tu Z; Li X; Wu Y; Li J; Zhang Q; Huang X
    Cancer Cell Int; 2020; 20():106. PubMed ID: 32265595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
    World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
    Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
    Front Immunol; 2021; 12():780509. PubMed ID: 35069551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
    Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
    Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2AFX might be a prognostic biomarker for hepatocellular carcinoma.
    Hu H; Zhong T; Jiang S
    Cancer Rep (Hoboken); 2023 Jan; 6(1):e1684. PubMed ID: 35903980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals.
    Dai W; Wang Y; Yang T; Wang J; Wu W; Gu J
    Cell Commun Signal; 2019 Sep; 17(1):113. PubMed ID: 31477130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
    Chen W; Chen X; Li S; Ren B
    J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
    Wang Z; Chen S; Wang G; Li S; Qin X
    Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
    Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
    Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
    Cai X; Zhou J; Deng J; Chen Z
    Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker.
    Xue C; Gao P; Cui X; Zhang X; Lei J; Li R; Zhu C; Qin X
    Front Oncol; 2021; 11():680070. PubMed ID: 34249720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma.
    Sang X; Wu F; Wu D; Lin S; Li J; Zhao N; Chen X; Xu A
    Front Genet; 2020; 11():112. PubMed ID: 32184801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
    Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
    Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.
    Yang J; Li H; Hu S; Zhou Y
    Aging (Albany NY); 2020 Apr; 12(8):6518-6535. PubMed ID: 32339157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma.
    Peng H; Zhu E; Wang J; Du X; Wang C; Yang M; Zhang Y
    Front Pharmacol; 2022; 13():989655. PubMed ID: 36120364
    [No Abstract]   [Full Text] [Related]  

  • 20. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
    Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
    J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.